Iovance Biotherapeutics, Inc. (IOVA) vs Spyre Therapeutics, Inc. (SYRE)
- Iovance Biotherapeutics, Inc. IOVA 13.58 −7.74%
- Spyre Therapeutics, Inc. SYRE 79.90 −0.25%
Iovance Biotherapeutics, Inc. and Spyre Therapeutics, Inc. are both Biotechnology companies. Spyre Therapeutics, Inc. is the larger, with a market value of $7.4B against $6.7B — 1.1× the size. Iovance Biotherapeutics, Inc. grew revenue faster over the last twelve months: 34.6% against −81.8%. Spyre Therapeutics, Inc. has the higher net margin (0.00% vs −89.1%) and the higher return on invested capital (0.00% vs −43.0%). Across the 16 metrics below, Spyre Therapeutics, Inc. leads on 12 and Iovance Biotherapeutics, Inc. on 4.
Valuation
Profitability
| Metric | IOVA | SYRE | Biotechnology median |
|---|---|---|---|
| Gross margin | 48.40% | 100.00% | 65.16% |
| Operating margin | (92.72%) | 0.00% | 0.00% |
| Net margin | (89.09%) | 0.00% | 0.00% |
| Free cash flow margin | (91.21%) | 0.00% | 0.00% |
| Return on equity | (40.36%) | (28.52%) | (56.36%) |
| Return on assets | (31.76%) | (20.90%) | (48.04%) |
| Return on invested capital | (42.96%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack